NO20092005L - MTP-Inhiberende piperidin- eller piperazinsubstituerte tetrahydro-naftalen-1-karboksylsyreforbindelser - Google Patents
MTP-Inhiberende piperidin- eller piperazinsubstituerte tetrahydro-naftalen-1-karboksylsyreforbindelserInfo
- Publication number
- NO20092005L NO20092005L NO20092005A NO20092005A NO20092005L NO 20092005 L NO20092005 L NO 20092005L NO 20092005 A NO20092005 A NO 20092005A NO 20092005 A NO20092005 A NO 20092005A NO 20092005 L NO20092005 L NO 20092005L
- Authority
- NO
- Norway
- Prior art keywords
- carboxylic acid
- piperidine
- naphthalene
- acid compounds
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/20—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06122817 | 2006-10-24 | ||
PCT/EP2007/061286 WO2008049806A1 (fr) | 2006-10-24 | 2007-10-22 | Composés inhibiteurs de la mtp de type acides tétrahydronaphtalène-1-carboxyliques substitués par un groupe pipéridinyle ou pipérazinyle |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20092005L true NO20092005L (no) | 2009-06-04 |
Family
ID=37885794
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20092005A NO20092005L (no) | 2006-10-24 | 2009-05-25 | MTP-Inhiberende piperidin- eller piperazinsubstituerte tetrahydro-naftalen-1-karboksylsyreforbindelser |
Country Status (28)
Country | Link |
---|---|
US (1) | US8114880B2 (fr) |
EP (1) | EP2076494B1 (fr) |
JP (1) | JP5506085B2 (fr) |
KR (1) | KR101415536B1 (fr) |
CN (1) | CN101528695B (fr) |
AR (1) | AR063517A1 (fr) |
AT (1) | ATE475648T1 (fr) |
AU (1) | AU2007310925B2 (fr) |
BR (1) | BRPI0717357A2 (fr) |
CA (1) | CA2664141C (fr) |
CL (1) | CL2007003042A1 (fr) |
CY (1) | CY1111010T1 (fr) |
DE (1) | DE602007008124D1 (fr) |
DK (1) | DK2076494T3 (fr) |
EA (1) | EA016311B1 (fr) |
HK (1) | HK1136823A1 (fr) |
IL (1) | IL198332A (fr) |
JO (1) | JO2653B1 (fr) |
MX (1) | MX2009004386A (fr) |
NO (1) | NO20092005L (fr) |
NZ (1) | NZ575615A (fr) |
PL (1) | PL2076494T3 (fr) |
PT (1) | PT2076494E (fr) |
SI (1) | SI2076494T1 (fr) |
TW (1) | TWI396688B (fr) |
UA (1) | UA99109C2 (fr) |
WO (1) | WO2008049806A1 (fr) |
ZA (1) | ZA200902822B (fr) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0211230D0 (en) | 2002-05-16 | 2002-06-26 | Medinnova Sf | Treatment of heart failure |
BRPI0717314A2 (pt) | 2006-10-24 | 2014-01-21 | Janssen Pharmaceutica Nv | Derivados de ácido tetra-hidro-naftaleno-1-carboxílico inibidores de mtp |
EP2025674A1 (fr) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Tetrahydronaphthaline substituée, son procédé de fabrication et son utilisation en tant que médicament |
EP2582709B1 (fr) | 2010-06-18 | 2018-01-24 | Sanofi | Dérivés d'azolopyridin-3-one en tant qu'inhibiteurs de lipases et de phospholipases |
PT2629776T (pt) * | 2010-10-18 | 2017-11-15 | Cerenis Therapeutics Holding Sa | Compostos, composições e métodos úteis para a mobilização de colesterol |
RU2737434C2 (ru) | 2013-03-13 | 2020-11-30 | Форма Терапьютикс, Инк. | Новые соединения и композиции для ингибирования fasn |
EP3484528B1 (fr) | 2016-07-18 | 2020-11-25 | Janssen Pharmaceutica NV | Ligands d'imagerie tep pour la protéine tau |
WO2019221192A1 (fr) * | 2018-05-15 | 2019-11-21 | 旭化成株式会社 | Procédé de production d'un ester d'aminoalkyle d'acide aminé ou d'un sel d'acide inorganique correspondant |
TWI767148B (zh) | 2018-10-10 | 2022-06-11 | 美商弗瑪治療公司 | 抑制脂肪酸合成酶(fasn) |
US10793554B2 (en) | 2018-10-29 | 2020-10-06 | Forma Therapeutics, Inc. | Solid forms of 4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl)piperazin-1-yl)(1-hydroxycyclopropyl)methanone |
WO2024006701A1 (fr) * | 2022-06-28 | 2024-01-04 | Stepan Company | Procédé de fabrication de sulfonates d'esters d'acides dialkyles |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5595872A (en) | 1992-03-06 | 1997-01-21 | Bristol-Myers Squibb Company | Nucleic acids encoding microsomal trigyceride transfer protein |
US5739135A (en) | 1993-09-03 | 1998-04-14 | Bristol-Myers Squibb Company | Inhibitors of microsomal triglyceride transfer protein and method |
WO1996040640A1 (fr) * | 1995-06-07 | 1996-12-19 | Pfizer Inc. | DERIVES DE BIPHENYL-2-ACIDE CARBOXYLIQUE-TETRAHYDRO-ISOQUINOLEINE-6-YL AMIDES, PREPARATION DE CES AMIDES ET UTILISATION EN TANT QU'INHIBITEURS DE LA PROTEINE DE TRANSFERT DE TRIGLYCERIDE MICROSOMAL ET/OU DE LA SECRETION D'APOLIPOPROTEINES B (Apo B) |
YU23499A (sh) | 1996-11-27 | 2001-07-10 | Pfizer Inc. | Inhibitorski amidi apo-b-sekrecije/mtp-a |
GB9826412D0 (en) | 1998-12-03 | 1999-01-27 | Glaxo Group Ltd | Chemical compounds |
DE19963235A1 (de) * | 1999-12-27 | 2001-07-05 | Boehringer Ingelheim Pharma | Substituierte Piperazinderivate, ihre Herstellung und ihre Verwendung als Arzneimittel |
GB0013346D0 (en) * | 2000-06-01 | 2000-07-26 | Glaxo Group Ltd | Therapeutic benzamide derivatives |
FR2816940A1 (fr) | 2000-11-23 | 2002-05-24 | Lipha | Derives de 4-(biphenylcarbonylamino)-piperidine, compositions les contenant et leur utilisation |
BRPI0717314A2 (pt) | 2006-10-24 | 2014-01-21 | Janssen Pharmaceutica Nv | Derivados de ácido tetra-hidro-naftaleno-1-carboxílico inibidores de mtp |
-
2007
- 2007-10-03 JO JO2007410A patent/JO2653B1/en active
- 2007-10-22 AU AU2007310925A patent/AU2007310925B2/en not_active Ceased
- 2007-10-22 WO PCT/EP2007/061286 patent/WO2008049806A1/fr active Application Filing
- 2007-10-22 EA EA200970398A patent/EA016311B1/ru not_active IP Right Cessation
- 2007-10-22 DK DK07821650.4T patent/DK2076494T3/da active
- 2007-10-22 BR BRPI0717357-1A2A patent/BRPI0717357A2/pt not_active IP Right Cessation
- 2007-10-22 DE DE602007008124T patent/DE602007008124D1/de active Active
- 2007-10-22 MX MX2009004386A patent/MX2009004386A/es active IP Right Grant
- 2007-10-22 NZ NZ575615A patent/NZ575615A/en not_active IP Right Cessation
- 2007-10-22 US US12/446,580 patent/US8114880B2/en not_active Expired - Fee Related
- 2007-10-22 PL PL07821650T patent/PL2076494T3/pl unknown
- 2007-10-22 AT AT07821650T patent/ATE475648T1/de active
- 2007-10-22 CA CA2664141A patent/CA2664141C/fr not_active Expired - Fee Related
- 2007-10-22 JP JP2009533800A patent/JP5506085B2/ja not_active Expired - Fee Related
- 2007-10-22 UA UAA200902359A patent/UA99109C2/ru unknown
- 2007-10-22 EP EP07821650A patent/EP2076494B1/fr active Active
- 2007-10-22 PT PT07821650T patent/PT2076494E/pt unknown
- 2007-10-22 CN CN2007800393884A patent/CN101528695B/zh not_active Expired - Fee Related
- 2007-10-22 SI SI200730371T patent/SI2076494T1/sl unknown
- 2007-10-22 KR KR1020097008396A patent/KR101415536B1/ko not_active IP Right Cessation
- 2007-10-23 AR ARP070104677A patent/AR063517A1/es not_active Application Discontinuation
- 2007-10-23 CL CL200703042A patent/CL2007003042A1/es unknown
- 2007-10-23 TW TW096139583A patent/TWI396688B/zh not_active IP Right Cessation
-
2009
- 2009-04-23 IL IL198332A patent/IL198332A/en active IP Right Grant
- 2009-04-23 ZA ZA200902822A patent/ZA200902822B/xx unknown
- 2009-05-25 NO NO20092005A patent/NO20092005L/no not_active Application Discontinuation
-
2010
- 2010-01-20 HK HK10100585.9A patent/HK1136823A1/xx not_active IP Right Cessation
- 2010-10-27 CY CY20101100974T patent/CY1111010T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20092005L (no) | MTP-Inhiberende piperidin- eller piperazinsubstituerte tetrahydro-naftalen-1-karboksylsyreforbindelser | |
JO2537B1 (en) | Aryl-pyridine or pyrezinate compounds replaced with heterogeneous pentagonal rings used as inhibitors of MTB proteins | |
NO20084874L (no) | Piendinylsubstituerte pyrrolidinoner som hemmere av 11-beta-hydroksysteroiddehydrogenase 1 | |
NO20090321L (no) | Anvendelse av substituerte 2-aminotyetraliner for produksjon av et medikament for forhindringen, lettingen og/eller behandlingen av diverse typer smerte | |
NO20085068L (no) | Fenylamino-benzoksazolsubstituerte karboksylsyrer, fremgangsmate for deres fremstilling og anvendelse derav som medikamenter | |
HRP20050103A2 (en) | N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein b secretion | |
NO20084318L (no) | Inhibitorer av II-beta-hydroksystereoid dehydrogenase I | |
NO20063103L (no) | N-aryl-piperidinsubstituerte bifenyl karboksamider | |
NO20060718L (no) | Substituerte tiofoner og deres anvendelse | |
DK2032534T3 (da) | 4-[(3-fluorphenoxy)phenylmethyl]piperidinmethansulfonat: anvendelser, fremgangsmåder til syntese og farmaceutiske præparater | |
MXPA05013772A (es) | 4-(aminometil)-piperidin benzamidas como antagonistas de 5ht4. | |
MX2009012518A (es) | Derivados de piperidina 4,4-disubstituidos. | |
NO20083853L (no) | Nye forbindelser | |
DE602007006833D1 (de) | Mtp-inhibierende tetrahydronaphthalin-1-carbonsäurederivate | |
NO20064601L (no) | Mtp-hemmende aryl-piperidiner eller -piperaziner substituert med 5-leddede heterocykler | |
SI1638959T1 (sl) | 5HT-antagonisticni 4-(aminometil)-piperidin benzamidi | |
ATE522530T1 (de) | 2-piperazin-1-yl-3h-imidazoä4,5-bü- pyridinderivate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |